<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:x="urn:schemas-microsoft-com:office:excel" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
        {font-family:"Cambria Math";
        panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
        {font-family:"Script MT Bold";
        panose-1:3 4 6 2 4 6 7 8 9 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0in;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
h1
        {mso-style-priority:9;
        mso-style-link:"Heading 1 Char";
        mso-margin-top-alt:auto;
        margin-right:0in;
        mso-margin-bottom-alt:auto;
        margin-left:0in;
        font-size:24.0pt;
        font-family:"Calibri",sans-serif;
        font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
        {mso-style-priority:99;
        mso-style-link:"Body Text Char";
        margin:0in;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:#0563C1;
        text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
        {mso-style-priority:99;
        color:#954F72;
        text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
        {mso-style-priority:34;
        margin:0in;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
span.EmailStyle17
        {mso-style-type:personal-compose;
        font-family:"Calibri",sans-serif;
        color:windowtext;}
span.Heading1Char
        {mso-style-name:"Heading 1 Char";
        mso-style-priority:9;
        mso-style-link:"Heading 1";
        font-family:"Calibri",sans-serif;
        font-weight:bold;}
span.BodyTextChar
        {mso-style-name:"Body Text Char";
        mso-style-priority:99;
        mso-style-link:"Body Text";
        font-family:"Calibri",sans-serif;}
.MsoChpDefault
        {mso-style-type:export-only;
        font-family:"Calibri",sans-serif;}
@page WordSection1
        {size:8.5in 11.0in;
        margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
        {page:WordSection1;}
@page WordSection2
        {size:8.5in 11.0in;
        margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection2
        {page:WordSection2;}
@page WordSection3
        {size:8.5in 11.0in;
        margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection3
        {page:WordSection3;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal">Please join us as we remotely attend the NYC Consultants Grand Rounds and Case Conference; Registration and other information is below:<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p><span style="font-size:12.0pt;color:black"><img width="934" height="207" style="width:9.7291in;height:2.1562in" id="img504179" src="cid:image001.png@01D8B7A7.8E212D30"><o:p></o:p></span></p>
<p><span style="font-size:12.0pt;color:black"><o:p> </o:p></span></p>
<p class="MsoBodyText" style="mso-margin-top-alt:11.7pt;margin-right:5.8pt;margin-bottom:0in;margin-left:11.0pt;margin-bottom:.0001pt">
<span style="font-size:12.0pt;color:black">Consultants' Conference is a monthly meeting attended by medical toxicologists, emergency physicians, pharmacists and other learners from all over the Northeast. It is an educational activity in which the
<i>Consultants </i>(renowned experts in various medical specialties) provide insight into the analysis and approach to the diagnosis and treatment of interesting toxicologic cases. The cases are presented mostly by the NYU Toxicology fellows in training, but
 anyone can present their case if deemed appropriate. Learners of all levels can benefit from the rich and often dynamic discourse.</span><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoBodyText"><span style="font-size:12.0pt;color:black"> </span><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoBodyText" style="mso-margin-top-alt:0in;margin-right:33.9pt;margin-bottom:0in;margin-left:11.0pt;margin-bottom:.0001pt;text-align:justify">
<span style="font-size:12.0pt;color:black">The next NYC PCC Grand Rounds and Consultants’ Conference will be held on September 1, 2022. Grand Rounds will start at 1PM EST and Consultants’ Conference will follow immediately. The topic and speaker will be:</span><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b><span style="font-size:12.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b><span style="font-size:12.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b><span style="font-size:12.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" align="center" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;text-align:center">
<b><span style="font-size:14.0pt;color:black">Dialyze It Off: Extracorporeal Therapies for Toxin Removal in Poisoning</span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" align="center" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;text-align:center">
<b><span style="font-size:14.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b><span style="font-size:14.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b><span style="font-size:14.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" align="center" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;text-align:center">
<b><span style="font-size:14.0pt;color:black">Joshua D. King, MD</span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" align="center" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;text-align:center">
<b><span style="font-size:14.0pt;color:black">Assistant Professor, Medicine and Pharmacy</span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" align="center" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;text-align:center">
<b><span style="font-size:14.0pt;color:black">Medical Director, Maryland Poison Center</span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" align="center" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;text-align:center">
<b><span style="font-size:14.0pt;color:black">Program Director, University of Maryland Nephrology Fellowship</span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" align="center" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;text-align:center">
<b><span style="font-size:14.0pt;color:black">University of Maryland</span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" align="center" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;text-align:center">
<b><span style="font-size:14.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b><span style="font-size:12.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoBodyText" style="mso-margin-top-alt:8.75pt;margin-right:7.8pt;margin-bottom:0in;margin-left:11.0pt;margin-bottom:.0001pt">
<span style="font-size:12.0pt;color:black">Consultants’ Conference will take place from 2 PM - 4 PM EST.</span><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoBodyText" style="margin-top:.55pt"><span style="font-size:12.0pt;color:black"> </span><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoBodyText" style="mso-margin-top-alt:0in;margin-right:8.15pt;margin-bottom:0in;margin-left:11.0pt;margin-bottom:.0001pt;line-height:97%">
<span style="font-size:12.0pt;line-height:97%;color:black">We will be broadcasting both the Grand Rounds lecture and Consultants’ Conference via the same link on WebEx AND
<span style="background:yellow;mso-highlight:yellow">WE WILL BE RESUMING THE LIVE CONFERENCE</span> in the auditorium at the Public Health Laboratory. Please click
</span><span style="font-size:12.0pt;line-height:97%;color:black"><a href="https://urldefense.com/v3/__https:/survey.alchemer.com/s3/5971719/Consultant-Conference?eventid=a1Q4V00000YT1YlUAL&programname=NYC*20poison*20control&center__;JSU!!GobTDDpD7A!Nz5KWF7R5N31_MiFpYfe5v0IlC-OMPUrHCPbu5-vLLSVWOs4w5E30QW4UbgkevsO6U1Q8gLs7YqLGbj_Y4MCdw$">here</a>
</span><span style="font-size:12.0pt;line-height:97%;color:black">to register and download the WebEx outlook file.<o:p></o:p></span></p>
<p class="MsoBodyText" style="mso-margin-top-alt:0in;margin-right:8.15pt;margin-bottom:0in;margin-left:11.0pt;margin-bottom:.0001pt;line-height:97%">
<span style="font-size:12.0pt;line-height:97%;color:black"><a href="https://urldefense.com/v3/__https://survey.alchemer.com/s3/5971719/Consultant-Conference?eventid=a1Q4V00000YT1YlUAL&programname=NYC*20poison*20control&center__;JSU!!GobTDDpD7A!M4jBXmOP_CzBkQer5Z8XIE8ASLAqOa9JkrZImLGCWo-uzYZZjFN2gIamYDhC7GSIKZskmTEy8fbFr_iuz8zWsVFl$">https://survey.alchemer.com/s3/5971719/Consultant-Conference?eventid=a1Q4V00000YT1YlUAL&programname=NYC%20poison%20control&center</a><o:p></o:p></span></p>
<p class="MsoBodyText" style="mso-margin-top-alt:0in;margin-right:8.15pt;margin-bottom:0in;margin-left:11.0pt;margin-bottom:.0001pt;line-height:97%">
<span style="font-size:12.0pt;line-height:97%;color:black"></span><span style="font-size:12.0pt;line-height:97%;color:black"><o:p></o:p></span></p>
<p class="MsoBodyText" style="mso-margin-top-alt:0in;margin-right:8.15pt;margin-bottom:0in;margin-left:11.0pt;margin-bottom:.0001pt;line-height:97%">
<span style="font-size:12.0pt;line-height:97%;color:black"> </span><span style="font-size:12.0pt;line-height:97%;color:black"><o:p></o:p></span></p>
<p class="MsoBodyText" style="mso-margin-top-alt:0in;margin-right:8.15pt;margin-bottom:0in;margin-left:11.0pt;margin-bottom:.0001pt;line-height:97%">
<b><span style="font-size:12.0pt;line-height:97%;color:black">Please Note: If you would like to receive this monthly announcement on a regular basis, please register for the conference at the link above, even if you are unable to attend.</span></b><span style="font-size:12.0pt;line-height:97%;color:black"><o:p></o:p></span></p>
<p class="MsoBodyText"><b><span style="font-size:12.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="100%" style="width:100.0%">
<tbody>
<tr>
<td style="padding:0in 0in 0in 0in">
<p class="MsoNormal" align="center" style="mso-margin-top-alt:.05in;margin-right:19.05pt;margin-bottom:0in;margin-left:19.3pt;margin-bottom:.0001pt;text-align:center;line-height:37.5pt;mso-line-height-rule:exactly">
<span style="font-size:32.0pt">Please post and distribute.</span><o:p></o:p></p>
<p class="MsoNormal" align="center" style="mso-margin-top-alt:0in;margin-right:19.05pt;margin-bottom:0in;margin-left:19.2pt;margin-bottom:.0001pt;text-align:center;line-height:37.3pt;mso-line-height-rule:exactly">
<span style="font-size:32.0pt">All are welcome.</span><o:p></o:p></p>
</td>
</tr>
</tbody>
</table>
</div>
<b><span style="font-size:12.0pt;font-family:"Calibri",sans-serif;color:black;mso-fareast-language:EN-US"><br clear="all" style="page-break-before:always">
</span></b>
<div class="WordSection2">
<p class="MsoBodyText" style="mso-margin-top-alt:3.8pt;margin-right:0in;margin-bottom:0in;margin-left:11.0pt;margin-bottom:.0001pt;text-indent:-11.0pt">
<span style="font-size:12.0pt;color:black">Cases to be discussed for Consultants’ Conference include:<o:p></o:p></span></p>
<p class="MsoBodyText"><b><span style="font-size:12.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;background:white">
<b><span style="font-size:12.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;background:white">
<span style="font-size:12.0pt;color:black"> </span><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoListParagraph" style="margin-left:.5in;mso-add-space:auto;background:white;text-autospace:ideograph-other">
<span style="font-size:12.0pt;color:black">1.</span><span style="font-size:7.0pt;font-family:"Times New Roman",serif;color:black">    
</span><span style="font-size:12.0pt;color:black">A previously healthy 2-year-old child presents to the ED with multiple generalized tonic-clonic  seizures and a subsequent PEA cardiac arrest. Return of spontaneous circulation is achieved after resuscitation
 and intubation in the field. His post ROSC vital signs in the ED are as follows: BP, 92/41 mmHg; HR, 104 beats minute; RR, intubated; T, 99.1 degrees Fahrenheit; O<sub>2</sub> Sat, 100% (on 40% FiO<sub>2</sub>), Point of care glucose, 104 mg/dL. A chest radiograph
 shows flecks of radiopaque material throughout his abdomen. <o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;margin-left:.25in;mso-add-space:auto;background:white">
<b><span style="font-size:12.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoListParagraph" style="background:white"><b><span style="font-size:12.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoListParagraph" style="background:white"><b><span style="font-size:12.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoListParagraph" style="background:white"><b><span style="font-size:12.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoListParagraph" style="margin-left:.5in"><span style="font-size:12.0pt;color:black">2.</span><span style="font-size:7.0pt;font-family:"Times New Roman",serif;color:black">    
</span><span style="font-size:12.0pt;color:black">A 40-year-old woman with no significant past medical history presents to the ED complaining of body-aches and tongue numbness after drinking an “herbal tea” she prepared to treat her father’s “rheumatic pain.”
 Her initial vital signs are: BP, 84/55 mmHg; HR, 60 beats/minute; RR 18, breaths/minute; T, 99 degrees Fahrenheit; O<sub>2</sub> Sat, 100% (RA).<o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b><span style="font-size:12.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoListParagraphCxSpFirst" style="margin-left:.5in;mso-add-space:auto;background:white;text-autospace:ideograph-other">
<b><span style="font-size:12.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoListParagraphCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;background:white;text-autospace:ideograph-other">
<b><span style="font-size:12.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoListParagraphCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;background:white;text-autospace:ideograph-other">
<b><span style="font-size:12.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoListParagraphCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;background:white;text-autospace:ideograph-other">
<b><span style="font-size:12.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoListParagraphCxSpMiddle" style="margin-left:.5in;mso-add-space:auto;background:white;text-autospace:ideograph-other">
<b><span style="font-size:12.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoListParagraphCxSpLast" style="margin-left:.5in;mso-add-space:auto;background:white;text-autospace:ideograph-other">
<span style="font-size:12.0pt;color:black">3.</span><span style="font-size:7.0pt;font-family:"Times New Roman",serif;color:black">    
</span><span style="font-size:12.0pt;color:black">A 37-year-old man with a history of seizure disorder presents to the ED with an elevated blood concentration of phenytoin. The patient was given a fosphenytoin load of 1000mg PE intravenously one day earlier
 after his neurology clinic found his blood phenytoin concentration to be subtherapeutic from blood obtained 3.5 weeks ago. The phenytoin blood concentration was 45.8 mcg/mL 2 hours after fosphenytoin administration and when repeated 19 hours later, was 44
 mcg/mL. The patient is currently asymptomatic; the PCC is consulted regarding the approach to management. His vital signs at the time are: BP, 131/84 mm/Hg; HR, 76 beats/minute; RR, 17  breaths/minute; T, 97.9 degrees Fahrenheit; O<sub>2</sub> Sat, 98% (RA).<br>
<br>
<br>
<br>
 <o:p></o:p></span></p>
<p class="MsoBodyText"><span style="font-size:12.0pt;color:black"> <o:p></o:p></span></p>
<p class="MsoBodyText"><span style="font-size:12.0pt;color:black"> <o:p></o:p></span></p>
<p class="MsoBodyText" style="margin-top:10.35pt"><span style="font-size:12.0pt;color:black">Mark K. Su, MD, MPH<o:p></o:p></span></p>
<p class="MsoBodyText" style="mso-margin-top-alt:.15pt;margin-right:0in;margin-bottom:0in;margin-left:11.0pt;margin-bottom:.0001pt;text-indent:-11.0pt">
<span style="font-size:12.0pt;color:black">Director, New York City Poison Control Center<o:p></o:p></span></p>
</div>
<span style="font-size:12.0pt;font-family:"Calibri",sans-serif;color:black;mso-fareast-language:EN-US"><br clear="all" style="page-break-before:always">
</span>
<div class="WordSection3">
<h1 style="margin-top:3.8pt"><span style="color:#212121">Jointly Provided by the NYU Grossman School of Medicine and the Poison Control Center.</span><span style="color:black"><o:p></o:p></span></h1>
<p class="MsoBodyText"><b><span style="font-size:12.0pt;color:black"> </span></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;margin-left:11.0pt;line-height:13.75pt;mso-line-height-rule:exactly">
<b><u><span style="font-size:12.0pt;color:#212121">Accreditation Statement</span></u></b><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoBodyText" style="mso-margin-top-alt:0in;margin-right:20.7pt;margin-bottom:0in;margin-left:11.0pt;margin-bottom:.0001pt">
<span style="font-size:12.0pt;color:#212121">This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the NYU
 School of Medicine and the Poison Control Center. The NYU Grossman School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.</span><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoBodyText" style="margin-top:.55pt"><span style="font-size:12.0pt;color:black"> </span><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<h1><u><span style="color:#212121">Credit Designation Statement</span></u><span style="color:black"><o:p></o:p></span></h1>
<p class="MsoBodyText" style="mso-margin-top-alt:.35pt;margin-right:10.6pt;margin-bottom:0in;margin-left:11.0pt;margin-bottom:.0001pt;line-height:96%">
<span style="font-size:12.0pt;line-height:96%;color:#212121">The NYU Grossman School of Medicine designates both of these as live activities for a maximum of 0.75
<i>AMA PRA Category 1 Credits<span style="position:relative;top:-4.0pt;mso-text-raise:4.0pt">TM
</span></i>for Toxicology Grand Rounds and 2 <i>AMA PRA Category 1 Credits<span style="position:relative;top:-4.0pt;mso-text-raise:4.0pt">TM
</span></i>for Consultants’ Conference. Physicians should claim only the credit commensurate with the extent of their participation in the activity.</span><span style="font-size:12.0pt;line-height:96%;color:black"><o:p></o:p></span></p>
<p class="MsoBodyText" style="margin-top:.2pt"><span style="font-size:12.0pt;color:black"> </span><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<h1 style="margin-top:.05pt"><u><span style="color:#212121">Disclosure Statement</span></u><span style="color:black"><o:p></o:p></span></h1>
<p class="MsoBodyText" style="mso-margin-top-alt:.1pt;margin-right:8.15pt;margin-bottom:0in;margin-left:11.0pt;margin-bottom:.0001pt">
<span style="font-size:12.0pt;color:#212121">The NYU Grossman School of Medicine adheres to ACCME accreditation requirements and policies, including the Standards for Commercial Support regarding industry support of continuing medical education. In order to
 resolve any identified Conflicts of Interest, disclosure information is provided during the planning process to ensure resolution of any identified conflicts. Disclosure of faculty and commercial relationships as well as the discussion of unlabeled or unapproved
 use of any drug, device or procedure by the faculty will be fully noted at the meeting.</span><span style="font-size:12.0pt;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><span style="font-family:"Script MT Bold"">Christine M. Stork, BSPharm, PharmD, MPH, DABAT, FAACT<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Script MT Bold"">Professor, Department of Emergency Medicine<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Script MT Bold"">Clinical Director, Upstate NY Poison Center<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Script MT Bold"">Upstate Medical University<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Script MT Bold"">Syracuse, NY<o:p></o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</body>
</html>